Det med 0.5 til 1,5 står i artikkelen til Haug i legetidsskriftet, samt i http://www.legemiddelhandboka.no og på noens ider til laboratoriene.

NEL er den andre siden, de som vil vente til TSH er 10 og er venner med danskene. Om de tyske endokrinologer some r enige om 0,3-1,2 tier de stille.
Ikke rart man blir feilmedisinert.
Fint at vi fikk det bevist, at gjengen med TSH til 10 har skrevet NEL.

De på hormonlabben på Aker må ha en stri strid.

Mary Shomon har skrevet om striden også, se http://thyroid.about.com/od/gettestedan ... bertsh.htm

"In late 2002, the National Academy of Clinical Biochemistry (NACB) issued new guidelines for the diagnosis and monitoring of thyroid disease. In the guidelines, the NACB reported that the current TSH reference range -- which usually runs from approximately 0.5 to 5.5 -- may be too wide and actually may include people with thyroid disease. When more sensitive screening was done, which excluded people with thyroid disease, 95 percent of the population tested actually had a TSH level between 0.4 and 2.5.
As a result, the NACB recommended reducing the reference range to that. Meaning, anything below or above that could be a sign of thyroid disease.
The NACB guidelines led to a recommendation in January 2003 by the American Association of Clinical Endocrinologists (AACE), calling for doctors to "consider treatment for patients who test outside the boundaries of a narrower margin based on a target TSH level of 0.3 to 3.0." The statement also said: "AACE believes the new range will result in proper diagnosis for millions of Americans who suffer from a mild thyroid disorder, but have gone untreated until now.

In research published in the Journal of the American Medical Association in 2003, Dr. Vahab Fatourechi and fellow resarchers estimated that if the range were narrowed according to the AACE recommendations, the total number of people with thyroid disease would expand from approximately 5 percent of the population to an estimated 20% of the population, with most of the added patient population falling in the hypothyroid/underactive category. This represents a dramatic increase in the number of thyroid patients nationwide, from an estimated 15 million, to a total of some 60 million Americans.

At the same time, however, a 2002 consensus conference made up of representatives from the key professional groups involved in thyroid treatment -- the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society -- published their findings in 2004, recommending against routine treatment of patients with TSH levels of 4.5 to 10.0 mIU/L. Many doctors, and the AACE itself, refer to the TSH test as the "gold standard" for measuring thyroid function. AACE recommendeds the new target range of 0.3 to 3.0. Yet, now, almost four years later, America's testing laboratories still use the old reference range of .05 to 5.5, and results are flagged by laboratories as abnormal only if they are outside the 0.5 to 5.5 reference range. And doctors remain divided. Among conventional physicians, some refuse to diagnose hypothyroidism unless the TSH test results are outside the traditional normal range, and flagged as abnormal by the laboratory. Other practitioners are following the recommendations of NACB and AACE, and are willing to diagnose hypothyroidism in patients with TSH levels above that range.
"
Altså har en enokrinologforening gått inn for lavere grenser for normal TSH, men NEL skriver ast det er veldig kontroversielt,
De er bare uenige, og mange følger allerede de nye anbefalingene, inkludertte endokrinologforeningen i tyskland.

(grunne for at de ikek vil behandle menensker med en TSH som er normal er fordi da mange flere menensker blir overbehandlet (de får lav TSH).......

Jeg får lav TSH, og mange andre, ved riktig behandlig. Nei, det vil de ikke snakke om.